^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
TGFBeta resistant HER2/EBV-CTLs
i
Other names: TGFBeta resistant HER2/EBV-CTLs, HER2 chimeric receptor & TGFbeta dominant negative receptor (DNF) expressing EBV specific lymphocytes
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Baylor Scott & White Research Institute
Drug class:
HER2-targeted CAR-T immunotherapy
Related drugs:
